This is getting serious, page-105

Everyone needs to calm down with the baseless conspiracy theories and the vitriol.
Placements like this are 100% of the time followed by a sell off. They call it indigestion as institutional and sophisticated investors typically bid for more than they want and then once they have confirmation of their acceptance will offload excess. In this case the additional options allow them to offload more than typical. Added to this we most likely have triggered margin calls and possibly also attracted some short selling. This downward pressure will end and the share price will find its level.
Fundamentals will be the focus again in a few weeks time or so. There is a lot to be pleased with in this deal. As LC made several references to the attractiveness of IMU now. There are a few milestones to pass and this company will be in play. Most of the big pharmaceutical companies have block buster drugs coming off patent and are desperate for pipeline of next generation block busters.
IMU is one of very few biotechs that offers such a prolific pipeline of opportunities all wrapped up in one tidy bow.

Be patient and trust in not one of the best but THE best team of people in this space today. It’s a dream acquisition for any big Pharma. Just my opinion. Not advice.